Download - Evonik Industries

More documents

Recommendations

Info

4 neWs New plant for organic specialty surfactants in China Evonik is building an integrated production plant for organic specialty surfactants at its site in Shanghai (China). With an investment volume in the upper double-digit million range, the production network± is scheduled to begin operation in mid 2013. The various specialty surfactants based on renewable raw materials will be used primarily for cosmetics and laundry care products, as well as for industrial applications. Evonik is a leading supplier in these areas. By building the plant at the Shanghai site, Evonik benefits from the infrastructure of the large Shanghai Chemical Industry Park (SCIP) and close proximity to its customers‘ production facilities. The integrated production network will feature state-of-the-art technology and meet correspondingly high environmental standards. Last fall, in its most recent project at SCIP, Evonik commissioned a plant for the production of plastics and plastics ingredients—a 250-million-euro investment for the Group. elements35 Issue 2|2011 The new integrated production plant will produce ingredients for cosmetics and laundry care products, as well as specialty surfactants for industrial applications. The Chinese cosmetics industry accounts for the lion‘s share of production. „We are already well-positioned in the market for cosmetic ingredients in Europe and the United States,“ says Dr. Claus Rettig, Catalysts for biodiesel: plant in Argentina planned Evonik Industries is planning to build a new facility to produce catalysts for the manufacture of biodiesel in Argentina. Basic engineering for this plant, which will have capacity of over 60,000 metric tons p.a., has now been completed and construction work is expected to start in July 2011. Following completion, which is scheduled for the end of 2012 at the latest, the plant will produce ready-to-use alcoholates for use as catalysts in the production of biodiesel from renewable raw mater ials. The project is still contingent on the approval of the relevant authorities. The plant will be located in Puerto General San Martin, in the Rosario region, at the heart of Argentina‘s biodiesel industry. Evonik is planning to build the plant on the same site as Terminal 6 S.A., which operates a large biodiesel facility. „Locating the facility at the Terminal 6 site enables us to use the existing infrastructure and gives us excellent logistics connections. It could therefore be erected swiftly, enabling us to supply catalysts competitively to customers in South America,“ comments Jan Van den Bergh, who heads the Advanced Intermediates Business The Chinese market for cosmetic ingredients is growing by 10 percent annually Unit. The new plant will supply especially Argentina and Brazil. Evonik has proven expertise in the production of biodiesel catalysts, backed up by many years of experience. In 2009 it started up a new production facility in Mobile (USA) with capacity of 60,000 metric tons p.a. This plant, which was built in just nine months, serves the growing North American market for biodiesel. Following the success of the new production technology at this US facility, the plan is to use the same technology for the new facil- head of the Consumer Specialties Business Unit. „Now we are following our customers to Asia, with state-of-the-art technology and correspondingly high-quality ingredients. This allows us to supply our customers at the accustomed high level of quality.“ China is expected to be the biggest market for cosmetics in Asia short-term, leaving Japan behind to number 2 position. The market in China will account for 25 percent of the global absolute growth of the upcoming five years. The Chinese market for cosmetic ingredients, which is mainly driven by multinational corporations, is growing by 10 percent annually. The main reason for this growth is the developing middle class in China, whose consumption patterns have changed in favor of higher qual ity products. In Asia, the market for laundry care products is driven by a growing environmental consciousness. Evonik’s products are particularly eco-friendly. For industrial specialty surfactants, the market is growing based on improved technology standards and increas ing regulatory requirements. With the con struction of the new integrated production plant, Evonik is also increasing its local capac ities in technical service, marketing and sales. ity in Argentina. In the new process, alcoholates are produced by reacting alcohol with a lye. Evonik is already a global market leader in biodiesel catalysts—a position it also holds in South America. „The planned new facility in Argentina strengthens our commitment to this region,“ says Van den Bergh. „In the midterm, we are anticipating strong double-digit growth in the biodiesel market.“ Evonik operates a facility in Niederkassel-Lülsdorf, near Cologne (Germany) as well as its facility in the USA.
Fiscal year 2010: the best result so far in the Chemicals core business „2010 was an outstanding year for us,“ commented Dr. Klaus Engel, Chairman of the Executive Board of Evonik Industries AG, at the financial press conference. The Group‘s core chemicals business reported by far the best performance in its history. In order to realize its focus on specialty chemicals, at the end of 2010 Evonik agreed to sell a majority stake in its energy business to a consortium of municipal utilities in Germany‘s Rhine- Ruhr region. As a result, the Energy Business Area has been reclassified to discontinued operations. In addition, further progress was made in amalgamating the residential real estate companies Evonik Immobilien GmbH and THS GmbH. „Our refocusing has almost been completed. In the future, the name Evonik will be synonymous with global leadership in specialty chemicals,“ said Engel. The focus is on the most important global megatrends. „We want to grow and increase our profitability further. To achieve that, in future the management of Evonik will be geared to making us faster, leaner and more flexible, with an even stronger market focus,“ said Engel. Additional Executive Board members appointed for chemicals business The Executive Board has therefore been increased to six members effective April 1, 2011. Patrik Wohlhauser (46) is the Executive Board member responsible for the Consumer, Health & Nutrition segment, Dr. Thomas Haeberle (54) is responsible for the Resource Efficiency segment and Dr. Dahai Yu (49) for the Specialty Materials segment. With an EBITDA margin of 18.3 percent, Evonik‘s core Chemicals Business Area: R&D spending [%] Development of new products 40 Basic research for new key technologies 19 Improved production processes for established products 24 Improved applications for established products 11 Other 6 chemicals business ranks among the sector leaders as of 2010. „We want to remain among the best in class in the future as well,“ said Engel. The Group has therefore embarked on key strategic investment projects. It is planning to invest €500 million in a new methionine facility in Singapore, which is scheduled to start producing feed additives in 2014. In addition, capacity for precipitated silicas in Asia and Europe is to be increased by 25 percent by 2014. Further, Evonik is planning to build a new facility for isophorone chemicals, prefer ably in Asia, to come on stream in 2013. The Group already occupies significant market positions in all three of these businesses and now aims to strengthen them selectively in the relevant growth markets. Group sales and earnings considerably higher than last year Group sales advanced 26 percent to € 13,300 million. Strong demand, high capacity utilization and improved margins lifted earnings before interest, taxes, depreciation, amortization and the non-operating result (EBITDA) 47 percent to € 2,365 million. The Group‘s EBITDA margin improved from 15.3 percent to 17.8 percent. Earnings before interest, taxes and the non-operating result (EBIT) surged 89 percent to € 1,639 million; net income tripled to € 734 million in 2010 (2009: € 240 million). In response to the economic crisis, Evonik introduced the „On Track“ efficiency enhancement program at the start of 2009. To bring a lasting improvement in competitiveness, the R&D in the Chemicals Business Area neWs 5 Group aims to achieve a sustained reduction in costs of € 500 million p.a. from 2012. All key cost items were analyzed and structures and processes were examined with a view to attaining this goal. By the end of 2010, specific measures had been defined to meet all target savings and over three quarters of the savings (almost € 400 million) had already been achieved. Chemicals reported a record performance The Chemicals Business Area grew sales by a strong 29 percent to € 12,867 million (2009: € 9,978 million). This was driven mainly by volumes and prices. In most business units demand was back at or even above the level seen in the first half of 2008, before the recession. As a result, many production facilities operated at full capacity. The effective action to cut costs and raise efficiency, together with a substantial rise in volumes, high capacity utilization, and increased margins boosted both EBITDA and EBIT to record levels. Earnings in all business units were well above the pre-recession level. EBITDA grew 47 percent year-on-year to € 2,357 million while EBIT surged 83 percent to € 1,702 million. Spending on R&D increased Evonik increased research and development spending by 13 percent to € 338 million in 2010 (2009: € 300 million). Around 60 percent of this was spent on the development of new products and new technology platforms. R&D employees approx. 2,300 Locations more than 35 Total R&D projects approx. 500 R&D projects focusing on resource efficiency approx. 100 Cooperation with universities and scientific institutes approx. 300 Number of new patent applications approx. 250 Patents (granted and pending) more than 24,000 Registered trademark (granted and pending) more than 7,500 elements35 Issue 2|2011
Page 1 and 2: elements35 Quarterly Science Newsle
Page 3: All set for the future If your car
Page 7 and 8: Plans for isophorone plants in Chin
Page 9 and 10: no MACHIne, PLAnt, engine would be
Page 11 and 12: ior of a liquid, which always becom
Page 13 and 14: Influence of the engine oil on gas
Page 15 and 16: Figure 1 Application areas of olefi
Page 17 and 18: Almost 5,000 km across Australia Pi
Page 19 and 20: Study verifies effectiveness of con
Page 21 and 22: PLAstIC oR GLAss? This is the quest
Page 23 and 24: The façade of the Photovoltaics In
Page 25 and 26: its partners, Sunovation has develo
Page 27 and 28: foR YeARs, It was impossible to ima
Page 29 and 30: 333 particularly since the situatio
Page 31 and 32: Robust, flexible, and fast drying:

Download - Evonik Industries

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?